Literature DB >> 10086393

Immunity to non-cerebral severe malaria is acquired after one or two infections.

S Gupta1, R W Snow, C A Donnelly, K Marsh, C Newbold.   

Abstract

In areas of stable transmission, clinical immunity to mild malaria is acquired slowly, so it is not usually effective until early adolescence. Life-threatening disease is, however, restricted to a much younger age group, indicating that resistance to the severe clinical consequences of infection is acquired more quickly. Understanding how rapidly immunity develops to severe malaria is essential, as severe malaria should be the primary target of intervention strategies, and predicting the result of interventions that reduce host exposure will require consideration of these dynamics. Severe disease in childhood is less frequent in areas where transmission is the greatest. One explanation for this is that infants experience increased exposure to infection while they are protected from disease, possibly by maternal antibody. They therefore emerge from this period of clinical protection with considerably more immunity than those who experience lower transmission intensities. Here we use this data, assuming a period of clinical protection, to estimate the number of prior infections needed to reduce the risk of severe disease to negligible levels. Contrary to expectations, one or two successful infective bites seem to be all that is necessary across a broad range of transmission intensities.

Entities:  

Mesh:

Year:  1999        PMID: 10086393     DOI: 10.1038/6560

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  179 in total

1.  Immunoglobulin G isotype responses to variant surface antigens of Plasmodium falciparum in healthy Gabonese adults and children during and after successive malaria attacks.

Authors:  Gerardo Cabrera; Clarisse Yone; Anne E Tebo; Jan van Aaken; Bertrand Lell; Peter G Kremsner; Adrian J F Luty
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 2.  Systems immunology of human malaria.

Authors:  Tuan M Tran; Babru Samal; Ewen Kirkness; Peter D Crompton
Journal:  Trends Parasitol       Date:  2012-05-15

Review 3.  Antigenic diversity and immune evasion by malaria parasites.

Authors:  Marcelo U Ferreira; Mônica da Silva Nunes; Gerhard Wunderlich
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

4.  Immunoglobulin G isotype responses to erythrocyte surface-expressed variant antigens of Plasmodium falciparum predict protection from malaria in African children.

Authors:  Clarisse L R P Yone; Peter G Kremsner; Adrian J F Luty
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

5.  Identification of target proteins of clinical immunity to Plasmodium falciparum in a region of low malaria transmission.

Authors:  Hirokazu Sakamoto; Satoru Takeo; Eizo Takashima; Kazutoyo Miura; Bernard N Kanoi; Takamasa Kaneko; Eun-Taek Han; Mayumi Tachibana; Kazuhiro Matsuoka; Jetsumon Sattabongkot; Rachanee Udomsangpetch; Tomoko Ishino; Takafumi Tsuboi
Journal:  Parasitol Int       Date:  2017-12-05       Impact factor: 2.230

Review 6.  Immune mechanisms in malaria: new insights in vaccine development.

Authors:  Eleanor M Riley; V Ann Stewart
Journal:  Nat Med       Date:  2013-02       Impact factor: 53.440

7.  Increased frequency of travel in the presence of cross-immunity may act to decrease the chance of a global pandemic.

Authors:  R N Thompson; C P Thompson; O Pelerman; S Gupta; U Obolski
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-06-24       Impact factor: 6.237

8.  Early effector cells survive the contraction phase in malaria infection and generate both central and effector memory T cells.

Authors:  Michael M Opata; Victor H Carpio; Samad A Ibitokou; Brian E Dillon; Joshua M Obiero; Robin Stephens
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

9.  Plasmodium falciparum var gene expression is modified by host immunity.

Authors:  George M Warimwe; Thomas M Keane; Gregory Fegan; Jennifer N Musyoki; Charles R J C Newton; Arnab Pain; Matthew Berriman; Kevin Marsh; Peter C Bull
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-11       Impact factor: 11.205

10.  Impact of indoor residual spraying of lambda-cyhalothrin on malaria prevalence and anemia in an epidemic-prone district of Muleba, north-western Tanzania.

Authors:  Fabian M Mashauri; Safari M Kinung'hi; Godfrey M Kaatano; Stephen M Magesa; Coleman Kishamawe; Joseph R Mwanga; Soori E Nnko; Robert C Malima; Chacha N Mero; Leonard E G Mboera
Journal:  Am J Trop Med Hyg       Date:  2013-03-04       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.